Relapse of leprosy after multidrug therapy.
Relapse of leprosy after multidrug therapy among leprosy patients treated at Mahasarakarm, Kalasin and Roi-et from 1984 to 1994 were analyzed. Twenty PB relapses (45.45%) and twenty four MB relapses (54.55%) were found among 5,298 originally classified PB patients and 5 MB relapses occurred in 2,624 originally classified MB patients. Mean relapse interval was between 3-4 years. The relapse rate within 10 years after stopping MDT was 0.83 per cent in PB and 0.19 per cent in MB. The estimated relapse rate per 1,000 patient-years was 1.55 for PB and 0.41 for MB respectively.
Dasananjali
K
K
Department of Communicable Disease Control, Ministry of Public Health, Nonthaburi, Thailand.
D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D009166:Mycobacterium leprae / Q000302:isolation & purification; D012008:Recurrence; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome
D007917:Leprostatic Agents